These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18667634)

  • 1. Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.
    Zhang X; Castelli FA; Zhu X; Wu M; Maillère B; BenMohamed L
    Clin Vaccine Immunol; 2008 Sep; 15(9):1436-49. PubMed ID: 18667634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.
    Chentoufi AA; Dasgupta G; Christensen ND; Hu J; Choudhury ZS; Azeem A; Jester JV; Nesburn AB; Wechsler SL; BenMohamed L
    J Immunol; 2010 Mar; 184(5):2561-71. PubMed ID: 20124097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.
    Kim M; Taylor J; Sidney J; Mikloska Z; Bodsworth N; Lagios K; Dunckley H; Byth-Wilson K; Denis M; Finlayson R; Khanna R; Sette A; Cunningham AL
    J Immunol; 2008 Nov; 181(9):6604-15. PubMed ID: 18941251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D.
    Chentoufi AA; Zhang X; Lamberth K; Dasgupta G; Bettahi I; Nguyen A; Wu M; Zhu X; Mohebbi A; Buus S; Wechsler SL; Nesburn AB; BenMohamed L
    J Immunol; 2008 Jan; 180(1):426-37. PubMed ID: 18097044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4
    Srivastava R; Coulon PA; Prakash S; Dhanushkodi NR; Roy S; Nguyen AM; Alomari NI; Mai UT; Amezquita C; Ye C; Maillère B; BenMohamed L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31915285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
    BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
    J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic HLA-A*02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes.
    Dervillez X; Qureshi H; Chentoufi AA; Khan AA; Kritzer E; Yu DC; Diaz OR; Gottimukkala C; Kalantari M; Villacres MC; Scarfone VM; McKinney DM; Sidney J; Sette A; Nesburn AB; Wechsler SL; BenMohamed L
    J Immunol; 2013 Nov; 191(10):5124-38. PubMed ID: 24101547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
    Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B.
    Chentoufi AA; Binder NR; Berka N; Durand G; Nguyen A; Bettahi I; Maillère B; BenMohamed L
    J Virol; 2008 Dec; 82(23):11792-802. PubMed ID: 18799581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic mice against ocular herpes.
    Srivastava R; Khan AA; Spencer D; Vahed H; Lopes PP; Thai NT; Wang C; Pham TT; Huang J; Scarfone VM; Nesburn AB; Wechsler SL; BenMohamed L
    J Immunol; 2015 Mar; 194(5):2232-48. PubMed ID: 25617474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8
    Lopes PP; Todorov G; Pham TT; Nesburn AB; Bahraoui E; BenMohamed L
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells.
    Ouwendijk WJ; Geluk A; Smits SL; Getu S; Osterhaus AD; Verjans GM
    J Immunol; 2014 Apr; 192(8):3730-9. PubMed ID: 24623134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes.
    Khan AA; Srivastava R; Spencer D; Garg S; Fremgen D; Vahed H; Lopes PP; Pham TT; Hewett C; Kuang J; Ong N; Huang L; Scarfone VM; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Apr; 89(7):3776-92. PubMed ID: 25609800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model.
    Srivastava R; Khan AA; Huang J; Nesburn AB; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4013-28. PubMed ID: 26098469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice.
    Li X; Zhang S; Lei J; Zhu Y; Zhou X; Xiao J; Xiang T
    Int Immunopharmacol; 2018 Aug; 61():100-108. PubMed ID: 29857239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.
    Mikloska Z; Cunningham AL
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice.
    Wang X; Xie G; Liao J; Yin D; Guan W; Pan M; Li J; Li Y
    Virol J; 2011 May; 8():232. PubMed ID: 21575169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.